Novavax (NVAX) EBIT Growth (1y) (2011 - 2026)
Novavax (NVAX) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 145.20% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 269.85% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 76.24% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -36.55% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,528.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 99.51% |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | -154.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -154.32% |
| Mar 31, 2026 | -102.99% |
| Dec 31, 2025 | 110.86% |
| Sep 30, 2025 | -32.83% |
| Jun 30, 2025 | -37.22% |
| Mar 31, 2025 | 455.94% |
| Dec 31, 2024 | 28.59% |
| Sep 30, 2024 | -6.68% |
| Jun 30, 2024 | 190.31% |
| Mar 31, 2024 | 53.69% |
| Dec 31, 2023 | 24.73% |
| Sep 30, 2023 | 1.22% |
| Jun 30, 2023 | 111.48% |
| Mar 31, 2023 | -249.44% |
| Dec 31, 2022 | 70.44% |
| Sep 30, 2022 | 58.59% |
| Jun 30, 2022 | -39.65% |
| Mar 31, 2022 | 200.32% |
| Dec 31, 2021 | -351.17% |
| Sep 30, 2021 | -58.37% |